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Oncogenomic screening in 
malignant neoplasias has led to the 
description of oncogenetic mechanisms 
and, recently, to the first successful 
targeted drug development approaches 
(1). Individual genomic abnormalities 
are used as diagnostic markers or for 
the individual prediction of clinical 
aggressiveness (2). However, most 
malignancies show nonrandom 
aberration patterns that may reflect 
the cooperation of multiple onco- and 
tumor suppressor genes, according to 
the multistep model of oncogenesis 
(3). The complexity of those changes 
warrants the application of advanced 
data mining methods for the devel-
opment of oncogenomic models.
A number of cytogenetic and 
molecular genetic techniques 
describe chromosomal imbalances 
or changes in the regional DNA 
content of tumor cells. Historically, 
the microscopic inspection of 
stained metaphase spreads (4) had 
been most widely applied, and still 
is the reference method, in many 
clinical applications. Comparative 
genomic hybridization (CGH) (5) 
permits the detection of genomic 
imbalances from tumor samples 
with more than 50% tumor cell 
content as well as from archival 
material (6). Recently, array or 
matrix CGH (7,8) has started 
to overcome the limited spatial 
resolution (9) of metaphase CGH.
An intriguing concept for 
oncogenomic data mining is the 
combination of the accumulated 
cytogenetic data with the molecular 
cytogenetic data from metaphase 
and array-based CGH experiments. 
However, complex annotation 
formats are used for the description 
of experimental results. The standards 
for cytogenetic banding and reverse in 
situ hybridization (ISH) (e.g., CGH) 
have been defined in the International 
System for Cytogenetic Nomenclature 
(ISCN) (10). The results of genomic 
microarray experiments usually are 
stored according to the minimal infor-
mation about a microarray experiment 
(MIAME) guidelines (11).
The largest publicly accessible 
resource for molecular cytogenetic 
screening data in oncology is the 
Mitelman Database of Chromosome 
Aberrations in Cancer (cgap.nci.nih.
gov/Chromosomes/Mitelman), which 
describes more than 46,000 samples 
analyzed by metaphase banding. 
Utilization of this data has been limited 
by the lack of a format amenable to data 
mining procedures, though valuable 
studies have been published by the 
database maintainers (12). Another 
resource is the National Center for 
Biotechnology Information (NCBI) 
spectral karyotyping (SKY)/CGH 
database (www.ncbi.nlm.nih.gov/sky/
skyweb.cgi) (13). It provides well-
structured clinical and experimental 
information for the included cases, 
but due to the reliance of the NCBI 
site on voluntary data submission 
it is, with currently 1006 included 
experiments, quantitatively limited. 
Recently (13), the Mitelman database 
and the SKY/CGH project have 
been integrated into NCBI’s Entrez 
Cancer Chromosomes site (www.ncbi.
nlm.nih.gov/entrez/query.fcgi?db= 
cancerchromosomes) and now offer 
band-specific search capabilities. 
By far, the largest collection of case-
specific CGH data are presented 
through the Progenetix web site 
(www.progenetix.net) (14), on which 
this article is focused.
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Figure 1. Cytogenetic 
data transformation, 
using comparative 
genomic hybridization 
(CGH) data as ex-
ample. (A) The 
various International 
System for Cytogenetic 
Nomenclature (ISCN)-
related annotation 
formats found in the 
literature are trans-
formed to standard 
reverse in situ hybrid-
ization (ISH) ISCN. (B) 
Contiguous aberration 
intervals are checked 
for their inclusion of 
chromosomal bands. 
(C) A band-specific sta-
tus annotation format 
serves as basis for data 
representation and 
analysis.
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The Progenetix project was initiated 
in December 2000. The main inclusion 
criterion was the complete description 
of the genomic status of each tumor 
specimen in a peer-reviewed article. 
Data sampling methods included 
copying of ISCN annotations from 
publication files or online supple-
ments and transcription of data from 
printed matter. For some array CGH 
data, pseudo-reverse ISH annota-
tions were generated (e.g., based on 
the Bioconductor DNAcopy package; 
www.bioconductor.org). For 72 articles, 
experimental results were provided by 
the authors of the original publications.
For the conversion of cytogenetic 
annotations, software was imple-
mented in the Perl scripting language 
(www.isc.org/sources/devel/lang/perl.
txt). Cytogenetic data are converted 
to standard ISCN 1995 format (Figure 
1A) and automatically checked for 
syntax errors. Each band of a cytoge-
netic reference table with 862 bands 
resolution [currently University of 
California Santa Cruz (UCSC) May 
2004 edition; hgdownload.cse.ucsc.
edu/goldenPath /hg17/da tabase /
cytoBand.txt.gz] is evaluated for its 
inclusion in intervals derived from the 
text annotation, and the status (gain, 
loss, or high-level gain) is assigned 
accordingly (Figure 1B). The band 
status is annotated, and a two-dimen-
sional band-specific status matrix file is 
generated (Figure 1C).
The minimal consistent amount of 
case-specific information is sampled 
from the literature. 
Diagnoses and topog-
raphies are recoded 
to the International 
Classification of Diseases 
in Oncology (ICD-O-
3) format (15). Each 
case is referenced to the 
PubMed ID of its origi-
nating publication. For 
the web site generation, 
all different case entities 
(disease, locus, publi-
cation, custom group) are 
identified, and for each of 
them, specific overview 
pages are generated. 
These consist of a list 
of case-specific infor-
mation, an ideogrammatic represen-
tation of genomic gains and losses, 
and a page showing the unsupervised 
clustering of cases according to their 
aberration pattern using XCluster 
(Gavin Sherlock; genetics.stanford.
edu/~sherlock/cluster.html).
At the time of writing, 13,240 
unique experiments published in 535 
peer-reviewed articles have been 
included into the Progenetix database 
(Figure 2), representing 273 distinct 
neoplastic entities. The majority of 
those cases (12,179 or 92%) came from 
chromosomal CGH experiments.
Progenetix presents a unique case-
specific structured overview of chromo-
somal imbalances for most neoplasias. 
After free registration, academic 
researchers are able to download the 
main database content, including the 
band-specific annotation data in an 
XML format. As an additional unique 
feature, the web site offers a query 
option for the relative aberration status 
of single bands in disease entities 
(Figure 3).
To allow users to convert, mine, 
and visualize their own molecular 
cytogenetic data sets, a version of the 
ISCN2matrix parser was implemented 
as a Perl CGI script. Users can upload a 
file containing data from multiple cases 
and generate chromosomal ideograms, 
Figure 2. Expansion of the Progenetix database. The thick line 
and open circles indicate the case numbers (left ordinate). The 
open boxes depict the number of included publications (right 
ordinate). The abscissa gives a linear time scale.
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Figure 3. A unique query option permits the search for tumor entities [as annotated by their 
International Classification of Diseases in Oncology (ICD-O-3) code] with a large number of 
imbalances involving a particular band. Given a suspected target gene, this feature allows the 
instantaneous identification of disease categories in which this gene could be deregulated based on 
frequent copy number changes. Here, the query for the MYCN locus on 2p24 shows the band to contain a 
local maximum for gains in neuroblastomas as well as in retinoblastomas.
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cluster graphics, and XML files as 
described above.
Recently, the interval-specific 
aberration information from the 
Progenetix data set and the parsing 
software for CGH, as well as 
metaphase banding-based annota-
tions, have shown their usefulness for 
the delineation of genomic aberration 
patterns with prognostic relevance (16) 
and for producing tumor type-specific 
combined genomic imbalance maps 
(17,18).
Large-scale data mining approaches 
based on tens of thousands of genomic 
profiles should lead to the identification 
of genomic signatures for a variety of 
neoplasias and the development of new 
diagnostic tools (e.g., disease-specific 
genomic arrays with low complexity). 
The integration of genomic aberration 
patterns will be of great benefit for 
the interpretation of expression array 
data, allowing for selection of genes 
with high probability of tumor-specific 
involvement. Additionally, the delin-
eation of recurring genomic aberration 
patterns may become the basis for 
the development of smart target gene 
detection methods, using sequence 
similarity searches over commonly 
involved loci. Through the powerful 
combination of advanced data mining 
tools with unique data content, the 
Progenetix project should be useful for 
a new generation of oncogenomic data 
mining projects.
ACKNOWLEDGMENTS
The author is indebted to all indi-
viduals who contributed their other-
wise not accessible original data. A 
list of contributors can be found on the 
Progenetix web site. Alejandra Ellison-
Barnes is thanked for helping with data 
transcription from printed matter.
COMPETING INTERESTS 
STATEMENT
The authors declare no competing 
interests.
REFERENCES
 1. Druker, B.J. and N.B. Lydon. 2000. Lessons 
learned from the development of an abl tyro-
sine kinase inhibitor for chronic myelogenous 
leukemia. J. Clin. Invest. 105:3-7.
 2. Dohner, H., S. Stilgenbauer, A. Benner, 
E. Leupolt, A. Krober, L. Bullinger, K. 
Dohner, M. Bentz, and P. Lichter. 2000. 
Genomic aberrations and survival in chronic 
lymphocytic leukemia. N. Engl. J. Med. 
343:1910-1916.
 3. Vogelstein, B. and K.W. Kinzler. 1993. The 
multistep nature of cancer. Trends Genet. 
9:138-141.
 4. Crossen, P.E. 1972. Giemsa banding patterns 
of human chromosomes. Clin. Genet. 3:169-
179.
 5. Kallioniemi, A., O.P. Kallioniemi, D. Sudar, 
D. Rutovitz, J.W. Gray, F. Waldman, and 
D. Pinkel. 1992. Comparative genomic hy-
bridization for molecular cytogenetic analysis 
of solid tumors. Science 258:818-821.
 6. Speicher, M.R., S. du Manoir, E. Schrock, 
H. Holtgreve-Grez, B. Schoell, C. Lengauer, 
T. Cremer, and T. Ried. 1993. Molecular 
cytogenetic analysis of formalin-fixed, paraf-
fin-embedded solid tumors by comparative 
genomic hybridization after universal DNA-
amplification. Hum. Mol. Genet. 2:1907-
1914.
 7. Solinas-Toldo, S., S. Lampel, S. 
Stilgenbauer, J. Nickolenko, A. Benner, H. 
Dohner, T. Cremer, and P. Lichter. 1997. 
Matrix-based comparative genomic hy-
bridization: biochips to screen for genomic 
imbalances. Genes Chromosomes Cancer 
20:399-407.
 8. Pinkel, D., R. Segraves, D. Sudar, S. Clark, 
I. Poole, D. Kowbel, C. Collins, W.L. Kuo, 
et al. 1998. High resolution analysis of DNA 
copy number variation using comparative 
genomic hybridization to microarrays. Nat. 
Genet. 20:207-211.
 9. Bentz, M., A. Plesch, S. Stilgenbauer, H. 
Dohner, and P. Lichter. 1998. Minimal sizes 
of deletions detected by comparative genomic 
hybridization. Genes Chromosomes Cancer 
21:172-175.
 10. Mitelman, F. (Ed.). 1995. International 
System for Cytogenetic Nomenclature. 
Karger, Basel.
 11. Brazma, A., P. Hingamp, J. Quackenbush, 
G. Sherlock, P. Spellman, C. Stoeckert, J. 
Aach, W. Ansorge, et al. 2001. Minimum 
information about a microarray experiment 
(MIAME)-toward standards for microarray 
data. Nat. Genet. 29:365-371.
 12. Hoglund, M., A. Frigyesi, T. Sall, D. 
Gisselsson, and F. Mitelman. 2005. 
Statistical behavior of complex cancer karyo-
types. Genes Chromosomes Cancer 42:327-
341.
 13. Knutsen, T., V. Gobu, R. Knaus, H. Padilla-
Nash, M. Augustus, R.L. Strausberg, I.R. 
Kirsch, K. Sirotkin, and T. Ried. 2005. The 
interactive online SKY/M-FISH & CGH da-
tabase and the Entrez cancer chromosomes 
search database: linkage of chromosomal 
aberrations with the genome sequence. Genes 
Chromosomes Cancer 44:52-64.
 14. Baudis, M. and M.L. Cleary. 2001. 
Progenetix.net: an online repository for 
molecular cytogenetic aberration data. 
Bioinformatics 17:1228-1229.
 15. Fritz, A., C. Percy, A. Jack, L.H. Sobin, 
and M.D. Parkin (Eds.). 2000. International 
Classification of Diseases for Oncology 
(ICD-O), 3rd ed. World Health Organization, 
Geneva.
 16. Vandesompele, J., M. Baudis, K. De Preter, 
N. Van Roy, P. Ambros, N. Bown, C. 
Brinkschmidt, H. Christiansen, et al. 2005. 
Unequivocal delineation of clinicogenetic 
subgroups and development of a new model 
for improved outcome prediction in neuro-
blastoma. J. Clin. Oncol. 23:2280-2299.
 17. Mao, X., R.A. Hamoudi, I.C. Talbot, and 
M. Baudis. Allele-specific loss of heterozy-
gosity in multiple colorectal adenomas: to-
wards the integrated molecular cytogenetic 
map II. Cancer Genet. Cytogenet. (In press).
 18. Mao, X., R.A. Hamoudi, P. Zhao, and M. 
Baudis. 2005. Genetic losses in breast cancer: 
toward an integrated molecular cytogenetic 
map. Cancer Genet. Cytogenet. 160:141-151.
Received 18 September 2005; 
accepted 9 November 2005.
Address correspondence to Michael 
Baudis, Division of Pediatric Hematology/
Oncology, 1600 SW Archer Rd., ARB-R4-
186, Gainesville, FL 32610-100296, USA. 
e-mail: mbaudis@ufl.edu
To purchase reprints  
of this article, contact 
Reprints@BioTechniques.com
